LearnDrugs.com
Cardiovascular

Vasopressors & Inotropes

High-yield High-alert Verified · Jul 2026

Prototype: norepinephrine

Catecholamines and related agents — the drugs that keep perfusion going in shock and cardiac arrest.

How it works in the body

The system involved, what goes wrong, and how the drug and body interact.

01 Shock — when perfusion fails

Shock is the state where blood pressure and flow fall so low that organs stop getting the oxygen they need. Blood pressure depends on two things: how hard the vessels squeeze (systemic vascular resistance) and how much blood the heart pumps (cardiac output). Different shocks fail differently — septic shock dilates the vessels; cardiogenic shock weakens the pump.

Vasopressors and inotropes are the emergency levers. They borrow the body’s own fight-or-flight (adrenergic) signaling to squeeze vessels, strengthen the heart, or both — buying time while the underlying cause is treated. They are high-alert, titrated to effect, usually in an ICU.

02 The adrenergic receptors — which lever each drug pulls

These drugs act on the same adrenergic receptors beta-blockers oppose, but in the opposite direction — they *stimulate* them. Alpha-1 (α1) receptors on blood vessels cause vasoconstriction (↑ resistance, ↑ BP). Beta-1 (β1) receptors on the heart increase rate and contractility (↑ cardiac output). Beta-2 (β2) relaxes vessels and airways.

Each drug is really a *recipe* of receptor effects. Norepinephrine (mostly α1, some β1) is the first-line pressor in septic shock — strong squeeze, modest cardiac boost. Phenylephrine is pure α1 (squeeze only). Dobutamine is mostly β1 — a pure inotrope for the failing pump, but it can lower BP. Epinephrine hits α and β hard (arrest, anaphylaxis). Dopamine’s effect shifts with the dose. Knowing the recipe tells you what each drug does and what to watch for.

Each agent is a mix of α1 (squeeze), β1 (pump), and β2 (relax) effects.

03 The catch — a powerful squeeze is dangerous where it leaks

The very vasoconstriction that saves a patient centrally becomes destructive if the drug leaks out of the vein. Extravasation of a vasopressor clamps down the local vessels so hard that the tissue loses its blood supply and can die (necrosis). This is why vasopressors are preferably given through a central line, and why the antidote — phentolamine, an α-blocker injected around the site — must be known.

Systemically, too much α1 squeeze can raise the workload on the heart and cause reflex effects and arrhythmias; too much β1 can cause tachyarrhythmias and ischemia. Every dose is a balance between enough perfusion pressure and too much.

Extravasation of a vasopressor → intense local vasoconstriction → ischemia → tissue necrosis; phentolamine reverses it.

Drug names

Generic Brand
norepinephrine Levophed
epinephrine Adrenalin
dopamine
dobutamine
phenylephrine Vazculep

Indications

  • Septic and other distributive shock (norepinephrine first-line)
  • Cardiogenic shock / decompensated heart failure (dobutamine — inotropic support)
  • Cardiac arrest and anaphylaxis (epinephrine); symptomatic hypotension/bradycardia

Mechanism of action

Stimulate adrenergic receptors: α1 (vasoconstriction → ↑ SVR/BP), β1 (↑ heart rate & contractility → ↑ cardiac output), and β2 (vasodilation/bronchodilation). Each agent has a distinct receptor profile — norepinephrine α1>β1, phenylephrine pure α1, dobutamine β1, epinephrine α+β, dopamine dose-dependent.

In plain terms
They flip on the body’s "fight-or-flight" signals to tighten blood vessels and/or strengthen the heart — raising blood pressure and flow.

Therapeutic effects — what you'll see working

Success is measured in real time: a rising mean arterial pressure (MAP, usually a target ≥ 65 mmHg), better organ perfusion (mentation, urine output, lactate clearing). Doses are titrated continuously — the goal is the lowest dose that restores perfusion.

↑ Blood pressure (MAP) ↑ Cardiac output Restored organ perfusion
↑ Blood pressure (MAP)
α1-mediated vasoconstriction raises systemic vascular resistance, restoring the perfusion pressure organs need — titrated to a MAP target (commonly ≥ 65 mmHg).
↑ Cardiac output
β1 stimulation (dobutamine, epinephrine, norepinephrine) increases the heart’s rate and force, moving more blood forward in a failing pump.
Restored organ perfusion
The end goal — judged by improving mentation, rising urine output, and a falling lactate — signals oxygen is reaching tissues again.

Adverse effects

The adverse effects are the adrenergic drive taken too far — excessive squeeze (ischemia), excessive cardiac stimulation (arrhythmias), and the local disaster of extravasation.

Caution: Common
Tachycardia, palpitations, anxiety, tremor, headache, hyperglycemia.
These are ordinary sympathetic effects — a racing heart, jitteriness, and (via glycogen breakdown) rising blood glucose. They are expected but are also early clues that the dose may be pushing too hard.
Warning: Serious Hold & notify
Extravasation necrosis, severe hypertension, tachy-/dysrhythmias, myocardial and peripheral/organ ischemia (including limb/digit and mesenteric).
Extravasation causes local tissue death — inspect the IV site continuously and give phentolamine for infiltration. Systemically, excessive α1 constriction can compromise blood flow to the fingers, toes, and gut, and β1 overdrive can trigger dangerous arrhythmias and cardiac ischemia.

Antidote

Phentolamine
An α-blocker infiltrated locally for extravasation — reverses the intense alpha-mediated vasoconstriction that otherwise causes tissue ischemia and necrosis.

Interactions

MAOIs / tricyclic antidepressants drug
Potentiate catecholamine effects → risk of severe hypertension and arrhythmias.

Contraindications

Most are relative — these are emergency drugs — but certain states make excessive vasoconstriction or cardiac stimulation especially hazardous.

Uncorrected hypovolemia use caution
Squeezing an empty tank raises pressure at the cost of perfusion — restore volume first; pressors are not a substitute for fluid.
Tachyarrhythmias / uncorrected tachycardia use caution
β1 stimulation can worsen a fast, unstable rhythm.
Peripheral/mesenteric vascular disease use caution
Potent α1 vasoconstriction can precipitate limb or gut ischemia in already-compromised circulation.
MAOIs / tricyclics; halothane anesthesia (relative) use caution
These potentiate catecholamine effects, risking severe hypertension or arrhythmias.

When to hold

Assess before giving — these findings mean hold the dose and act.

Route & titration
Give via a central line whenever possible on an infusion pump, titrated to a MAP/BP target (commonly MAP ≥ 65 mmHg).
IV-site extravasation (blanching, swelling, pain)
Stop the infusion and infiltrate phentolamine around the site — tissue-necrosis risk.

Nursing considerations

The RN-specific layer — each action paired with the reason it matters.

Administration & the IV site
Give via infusion pump, titrated to a MAP/BP target, through a central line whenever possible.
Why: These are high-alert, dose-critical drugs; central access reduces the risk of extravasation necrosis from a potent vasoconstrictor.
Inspect the IV site continuously for blanching, coolness, or swelling; if extravasation occurs, stop the infusion and give phentolamine per protocol.
Why: Vasopressor leakage causes rapid local ischemia; phentolamine is the α-blocker antidote that restores blood flow and prevents necrosis.
Never stop an infusion abruptly — wean/titrate down.
Why: Sudden withdrawal of vasoconstrictor support can cause a precipitous drop in blood pressure.
Monitoring
Monitor continuous ECG, arterial blood pressure, and perfusion (mentation, urine output, extremities, lactate).
Why: These agents are titrated moment to moment; ECG catches arrhythmias and perfusion markers confirm the drug is helping, not harming.
Watch for dysrhythmias, chest pain, and cold/dusky extremities; report signs of organ or limb ischemia.
Why: Excessive β1 drive causes arrhythmias/ischemia, and excessive α1 squeeze can compromise peripheral and mesenteric circulation.

Sources

Educational summary for nursing students. Always verify against current prescribing information and your institution's protocols before administering. Not medical advice.